Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1995Clinical Microbiology ReviewsOpen Access

Antiviral therapy for human immunodeficiency virus infections

View Full Paper
Ask AI
Bookmark
Share

Authors

Erik De Clercq
Erik De ClercqRega Institute for Medical Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Erik De Clercq (1995) studied this question.

synapsesocial.com/papers/6a1f5299d09bc027e4835210https://doi.org/10.1128/cmr.8.2.200
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preparation and anti-HIV activities of aurintricarboxylic acid fractions and analogs: direct correlation of antiviral potency with molecular weight1991 · 82 citations
  2. 2HIV‐1‐specific RT inhibitors: Highly selective inhibitors of human immunodeficiency virus type 1 that are specifically targeted at the viral reverse transcriptase1993 · 166 citations
  3. 3Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors1992 · 75 citations
  4. 4HP 0.35, a cephalosporin degradation product is a specific inhibitor of lentiviral RNAses H1991 · 21 citations
  5. 5Differential Activity of Polyanionic Compounds and Castanospermine against HIV Replication and HIV-Induced Syncytium Formation Depending on Virus Strain and Cell Type1992 · 26 citations